Raily Aesthetic Medicine International Holdings Limited released its earnings results on Mar 28, 2025. The company reported -HK$0.112 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.112.

Is Raily Aesthetic Medicine International Holdings Limited overvalued?

According to Wall Street analysts Raily Aesthetic Medicine International Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Raily Aesthetic Medicine International Holdings Limited pay dividends?

Raily Aesthetic Medicine International Holdings Limited does not currently pay dividends.

What is Raily Aesthetic Medicine International Holdings Limited’s EPS estimate?

Raily Aesthetic Medicine International Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Raily Aesthetic Medicine International Holdings Limited have?

Raily Aesthetic Medicine International Holdings Limited has 557,077,330 shares outstanding.

What happened to Raily Aesthetic Medicine International Holdings Limited’s price movement after its last earnings report?

Raily Aesthetic Medicine International Holdings Limited reported an EPS of -HK$0.112 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.091%.

Which hedge fund is a major shareholder of Raily Aesthetic Medicine International Holdings Limited?

Currently, no hedge funds are holding shares in HK:2135

Raily Aesthetic Medicine International Holdings Limited Stock Smart Score

Underperform

News Sentiment

Neutral

Bullish news 59%
Bearish news 100%

Technicals

Fundamentals

Return on Equity

-48.87%

Trailing 12-Months

Asset Growth

-11.71%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Raily Aesthetic Medicine International Holdings Limited

Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services. The company operates through three segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Its services include aesthetic surgery services, including aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, primarily comprising aesthetic injection procedures; aesthetic dermatology services, such as various aesthetic energy-based procedures; and aesthetic medical management consulting services. The company also offers aesthetic dental services, including orthodontics, and dental implant and whitening; and trades in medical equipment. In addition, it sells surgical implants and aesthetic medical skincare products. The company owns and operates a network of four private for-profit aesthetic medical institutions in Zhejiang and Anhui Province, the People's Republic of China. It serves individual retail clients and aesthetic medical institutions. The company was founded in 2008 and is headquartered in Hangzhou, the People's Republic of China. Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.